Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer

Journal of Surgical Oncology

Volumn 92, Issue 4, 2005, Pages 299-303

  Altinyollar, Huseyin ^a,b   Dingil, Gurbuz ^a   Berberoglu, Ugur ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Kentkoop Mah ^*  (Turkey)

Author keywords

Infraclavicular lymph nodes; Ultrasonography

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CLAVICLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 28844435050     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20379     Document Type: Article

References (20)

1. Singletary SE, Alfred C, Ashley P, et al.: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-3636.
2. Schwartz GF, Hortobagy GN. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania. Cancer 2004;100:2512-2532.
3. Buchholz TA, Hunt KK, Whitman GJ, et al.: Neoadjuvant chemotherapy for breast carcinoma: Multidisciplinary considerations of benefits and risks. Cancer 2003;98:1150-1160.
4. Newman LA, Kuerer HM, Fornage B, et al.: Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg 2001;181:313-318.
5. de Kanter AY, van Eijck CH, van Geel AN, et al.: Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 1999;86:1459-1462.
6. Tateishi T, Machi J, Feleppa EJ, et al.: In vitro B-mode ultrasonographic criteria for diagnosing axillary lymph node metastases of breast cancer. J Ultrasound Med 1999;18:349-356.
7. Fisher B, Bauer M, Wickerham DL, et al.: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer 1983;28:282-291.
8. Wilking N, Rutqvist LE, Cartensen J, et al.: Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol 1992;31:29-35.
9. Saha S, Ferrar WB, Yofng DC, et al.: Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients. J Surg Oncol 2000;73:134-137.
10. Obwegeser R, Lorenz K, Hohlagschwandtner M, et al.: Axillary lymph nodes in breast cancer: Is size related to metastatic involvement? World J Surg 2000;24:546-550.
11. Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin based neoadjuvant chemotherapy. J Clin Oncol 1999;17:460-469.
12. Kuerer HM, Newman LA, Buzdar AU, et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease free survival in patients with locally advanced breast cancer. Am J Surg 1998;176:502-508.
13. Smith IE, Walsh G, Jones A, et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 1995;13:424-429.
14. Fisher B, Redmond C, Fisher ER, et al.: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-681.
15. Cabanes PA, Salmon RJ, Durand JC, et al.: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-1248.
16. Hellman S, Haris JR. The appropriate breast cancer paradigm. Cancer Res 1987;47:339-342.
17. Noguchi M, Katev N, Miyazaki I. Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat 1996;40:283-293.
18. Fornage BD, Coan JD, David CL. Ultrasound-guided needle biopsy of the breast and other interventional procedures. Radiol Clin North Am 1992;30:167-185.
19. Tate JJT, Lewis V. Archer T, et al. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989;15:139-141.
20. Kuerer HM, Newman LA, Fornage BD, et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 1998;5:673-680.